Inventor · disambiguated record
John Mcwhirter
Also filed as: MCWHIRTER JOHN · MCWHIRTER JOHN A
73 granted patents·48 pending applications·691 citations·filing 1977–2025
99Inventor score
Top patents by PatentIndex Score
121 records- 0199US10412940B2Mice expressing a limited immunoglobulin light chain repertoireREGENERON PHARMA·Filed 2018·Granted Sep 17, 2019·38 cites·15 claims
- 0298US9332742B2Histidine engineered light chain antibodies and genetically modified non-human animals for generating the sameREGENERON PHARMA·Filed 2015·Granted May 10, 2016·19 cites·30 claims
- 0398US9113616B2Genetically modified mice having humanized TCR variable genesREGENERON PHARMA·Filed 2012·Granted Aug 25, 2015·67 cites·42 claims
- 0497US9795121B2Humanized C3 animalsREGENERON PHARMA·Filed 2015·Granted Oct 24, 2017·18 cites·23 claims
- 0597US9796788B2Mice expressing a limited immunoglobulin light chain repertoireREGENERON PHARMA·Filed 2013·Granted Oct 24, 2017·26 cites·12 claims
- 0697US9334334B2Histidine engineered light chain antibodies and genetically modified non-human animals for generating the sameREGENERON PHARMA·Filed 2013·Granted May 10, 2016·31 cites·44 claims
- 0797US9301510B2Mice that produce antigen-binding proteins with pH-dependent binding characteristicsREGENERON PHARMA·Filed 2013·Granted Apr 5, 2016·28 cites·35 claims
- 0897US9204624B2Non-human animals with modifed immunoglobulin heavy chain sequencesREGENERON PHARMA·Filed 2014·Granted Dec 8, 2015·30 cites·27 claims
- 0996US10167344B2Mice expressing a limited immunoglobulin light chain repertoireREGENERON PHARMA·Filed 2017·Granted Jan 1, 2019·7 cites·11 claims
- 1096US10143186B2Common light chain mouseMCWHIRTER JOHN·Filed 2011·Granted Dec 4, 2018·34 cites·28 claims
- 1196US8114403B2Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereofBOWDISH KATHERINE S·Filed 2010·Granted Feb 14, 2012·23 cites·3 claims
- 1295US11666040B2Humanized non-human animals with restricted immunoglobulin heavy chain lociREGENERON PHARMA·Filed 2020·Granted Jun 6, 2023·3 cites·46 claims
- 1395US10130081B2Humanized universal light chain miceMCWHIRTER JOHN·Filed 2012·Granted Nov 20, 2018·21 cites·19 claims
- 1495US9969814B2Methods for making fully human bispecific antibodies using a common light chainREGENERON PHARMA·Filed 2014·Granted May 15, 2018·18 cites·15 claims
- 1595US9930871B2Non-human animals with modified immunoglobulin heavy chain sequencesREGENERON PHARMA·Filed 2015·Granted Apr 3, 2018·7 cites·27 claims
- 1695US9738897B2Nuclease-mediated DNA assemblyREGENERON PHARMA·Filed 2015·Granted Aug 22, 2017·13 cites·29 claims
- 1795US8840885B2Methods for treating chronic lymphocytic leukemiaBOWDISH KATHERINE S·Filed 2011·Granted Sep 23, 2014·12 cites·5 claims
- 1895US7435412B2Chronic lymphocytic leukemia cell lineALEXION PHARMA INC·Filed 2003·Granted Oct 14, 2008·34 cites·15 claims
- 1994US11357217B2Humanized universal light chain miceREGENERAN PHARMACEUTICALS INC·Filed 2018·Granted Jun 14, 2022·7 cites·25 claims
- 2094US10238093B2Humanized non-human animals with restricted immunoglobulin heavy chain lociREGENERON PHARMA·Filed 2013·Granted Mar 26, 2019·12 cites·27 claims
- 2194US7408041B2Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereofALEXION PHARMA INC·Filed 2004·Granted Aug 5, 2008·39 cites·16 claims
- 2293US11559050B2Humanized non-human animals with restricted immunoglobulin heavy chain lociREGENERON PHARMA·Filed 2019·Granted Jan 24, 2023·4 cites·22 claims
- 2393US9801362B2Non-human animals expressing pH-sensitive immunoglobulin sequencesREGENERON PHARMA·Filed 2013·Granted Oct 31, 2017·9 cites·43 claims
- 2493US9648856B2Non-human animals expressing pH-sensitive immunoglobulin sequencesREGENERON PHARMA·Filed 2013·Granted May 16, 2017·9 cites·20 claims
- 2593US9580715B2Nuclease-mediated DNA assemblyREGENERON PHARMA·Filed 2015·Granted Feb 28, 2017·7 cites·30 claims
- 2692US9615550B2Genetically modified major histocompatibility complex miceREGENERON PHARMA·Filed 2012·Granted Apr 11, 2017·12 cites·7 claims
- 2792US9591835B2Genetically modified major histocompatibility complex animalsREGENERON PHARMA·Filed 2013·Granted Mar 14, 2017·11 cites·6 claims
- 2891USRE41365ENested oligonucleotides containing a hairpin for nucleic acid amplificationALEXION PHARMA INC·Filed 2009·Granted Jun 1, 2010·15 cites·38 claims
- 2991US7598353B2Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereofALEXION PHARMA INC·Filed 2008·Granted Oct 6, 2009·10 cites·13 claims
- 3090US12389888B2Mice expressing a limited immunoglobulin light chain repertoireREGENERON PHARMA·Filed 2021·Granted Aug 19, 2025·1 cites·12 claims
- 3190US9150661B2Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereofBOWDISH KATHERINE S·Filed 2012·Granted Oct 6, 2015·7 cites·7 claims
- 3290US8187877B2Chronic lymphocytic leukemia cell lineBOWDISH KATHERINE S·Filed 2008·Granted May 29, 2012·7 cites·1 claims
- 3389US12110502B2Models of tauopathyREGENERON PHARMA·Filed 2023·Granted Oct 8, 2024·1 cites·42 claims
- 3489US11845957B2Models of tauopathyREGENERON PHARMA·Filed 2020·Granted Dec 19, 2023·2 cites·51 claims
- 3589US9730435B2Non-human animals having a humanized a proliferation-inducing ligand geneREGENERON PHARMA·Filed 2014·Granted Aug 15, 2017·5 cites·8 claims
- 3689US9629347B2Non-human animals having a humanized B-cell activating factor geneREGENERON PHARMA·Filed 2014·Granted Apr 25, 2017·6 cites·7 claims
- 3788US11261248B2Restricted immunoglobulin heavy chain miceREGENERON PHARMA·Filed 2019·Granted Mar 1, 2022·2 cites·7 claims
- 3888US11026407B2Mice expressing a limited immunoglobulin light chain repertoireREGENERON PHARMA·Filed 2019·Granted Jun 8, 2021·2 cites·14 claims
- 3988US10820582B2Non-human animals having an engineered immunoglobulin Λ light chain locusREGENERON PHARMA·Filed 2017·Granted Nov 3, 2020·3 cites·21 claims
- 4088US9963501B2B cell lineage based immunogen design with humanized animalsREGENERON PHARMA·Filed 2014·Granted May 8, 2018·6 cites·14 claims
- 4188US7714110B2Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereofALEXION PHARMA INC·Filed 2008·Granted May 11, 2010·8 cites·17 claims
- 4287US10219494B2Non-human animals having a humanized B-cell activating factor geneREGENERON PHARMA·Filed 2017·Granted Mar 5, 2019·2 cites·10 claims
- 4387US2024229048A1Nuclease-mediated dna assemblyREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 4486US11000020B2Non-human animals having a humanized B-cell activating factor geneREGENERON PHARMA·Filed 2019·Granted May 11, 2021·1 cites·6 claims
- 4586US10246509B2Restricted immunoglobulin heavy chain miceREGENERON PHARMA·Filed 2012·Granted Apr 2, 2019·6 cites·24 claims
- 4686US7427665B2Chronic lymphocytic leukemia cell lineALEXION PHARMA INC·Filed 2001·Granted Sep 23, 2008·20 cites·9 claims
- 4785US2024180130A1Non-human animals with modified immunoglobulin heavy chain sequencesREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 4884US11051498B2Mouse having an engineered immunoglobulin lambda light chainREGENERON PHARMA·Filed 2018·Granted Jul 6, 2021·2 cites·14 claims
- 4984US10869466B2Genetically modified major histocompatibility complex miceREGENERON PHARMA·Filed 2017·Granted Dec 22, 2020·2 cites·18 claims
- 5084US2024065238A1Humanized non-human animals with restricted immunoglobulin heavy chain lociREGENERON PHARMA·Filed 2023·Application pending·0 cites
Showing the top 50 of 121 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when John Mcwhirter files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →